Drug Profile
Research programme: hepatocellular carcinoma therapeutics - Enzo Biochem
Alternative Names: Leptin - Enzo BiochemLatest Information Update: 30 Sep 2009
Price :
$50
*
At a glance
- Originator Enzo Biochem
- Class Intracellular signalling peptides and proteins; Peptide hormones
- Mechanism of Action Natural killer cell stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Liver cancer
Most Recent Events
- 30 Sep 2009 Discontinued - Preclinical for liver cancer in USA (unspecified route)
- 11 Jul 2005 Preclinical trials in liver cancer in USA (unspecified route)